drugset / Trial / NCT01450839
E2022 Patch Formulation Multiple Dose Study
RandomizedCrossoverTriple-blindTreatment
Summary
This study is to evaluate the safety and tolerability of a E2022 16 mg tape when applied repeatedly for 17 days to healthy elderly Japanese male subjects, using E2022 placebo tape as the control.
Timeline
- Start
- 2011-09
- Primary completion
- 2011-11
- Completion
- 2012-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Donepezil | Small molecule | 5 mg | Topical |
| Subject | Donepezil | Small molecule | 16 mg | Topical |
Indications
No indication recorded.